COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 38361868.
- Also identified by DOI 10.4103/jfmpc.jfmpc_314_23 and PMC identifier 10866268.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many cases of telogen effluvium (TE), acute hair shedding, following coronavirus disease 2019 (COVID-19) were reported during the pandemic. We conducted a cross-sectional study to assess the relationship between COVID-19 and TE in Saudi Arabia. Self-administered online questionnaires were distributed online between March and September 2022 in Saudi Arabia. A multivariate logistic regression model was used to determine risk factors associated with TE post-COVID-19 (significance at <i>P</i> < 0.05). Of the 703 responders, 392 were included in the study. 59.70% (<i>n</i> = 234) recognized hair shedding during or after COVID-19. The time taken to realize hair shedding (3 or 6 months) and the duration varied (3, 6, >6 months). The risk factors significantly related to TE post-COVID-19 were: female sex (<i>P</i> < 0.001, odds ratio [OR] = 2.98), COVID-19 antiviral treatment (<i>P</i> = 0.032, OR = 3.02), and TE history (<i>P</i> = 0.001, OR = 3.78). Healthcare providers and physicians should be aware of the relationship between TE and COVID-19, to easily recognize, treat, and improve their patients' outcomes).